Ensysce Biosciences News

POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Apr 20 05:20

Ensysce Biosciences | 8-K: Current report

Mar 29 20:02

Ensysce Biosciences | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Mar 27 04:46

Ensysce Biosciences | 8-K: Ensysce Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 15 20:15

Ensysce Biosciences | 8-K: Current report

Feb 15 06:35

Ensysce Biosciences | S-1: General form for registration of securities under the Securities Act of 1933

Jan 17 13:00

Ensysce Biosciences | 8-K: Current report

Dec 29, 2023 13:00

Ensysce Biosciences | DEFA14A: Others

Dec 20, 2023 05:27

Ensysce Biosciences | 8-K: Current report

Dec 20, 2023 05:24

Ensysce Biosciences | 8-K: Current report

Nov 29, 2023 22:24

Ensysce Biosciences | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Nov 18, 2023 06:19

Ensysce Biosciences | 8-K: Current report

Nov 18, 2023 05:15

Ensysce Biosciences | DEFA14A: Others

Nov 10, 2023 10:25

Ensysce Biosciences | DEF 14A: Definitive information statements

Nov 10, 2023 10:22

Ensysce Biosciences | S-1: General form for registration of securities under the Securities Act of 1933

Nov 10, 2023 06:06

Ensysce Biosciences | 8-K: Ensysce Biosciences Reports Third Quarter 2023 Financial Results

Nov 10, 2023 06:02

Ensysce Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Oct 31, 2023 05:04

Ensysce Biosciences | 8-K: Current report

Oct 24, 2023 19:59

Ensysce Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Oct 20, 2023 07:48

Ensysce Biosciences | 8-K: Current report

Aug 29, 2023 05:20